Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma
Open Access
- 22 August 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 884
Abstract
Aims: This study aimed to identify potential, non-invasive biomarkers for diagnosis and monitoring of the progress in multiple myeloma (MM) patients. Methods: MM patients and age-matched healthy controls (HC) were recruited in Discovery phase and Validation phase, respectively. MM patients were segregated into active group (AG) and responding group (RG). Serum samples were collected were conducted to non-targeted metabolomics analyses. Metabolites which were significantly changed (SCMs) among groups were identified in Discovery phase and was validated in Validation phase. The signaling pathways of these SCMs were enriched. The ability of SCMs to discriminate among groups in Validation phase was analyzed through receiver operating characteristic curve. The correlations between SCMs and clinical features, between SCMs and survival period of MM patients were analyzed. Results: Total of 23 SCMs were identified in AG compared with HC both in Discovery phase and Validation phase. Those SCMs were significantly enriched in arginine and proline metabolism and glycerophospholipid metabolism. 4 SCMs had the discriminatory ability between MM patients and healthy controls in Validation phase. Moreover, 12 SCMs had the ability to discriminate between the AG patients and RG patients in Validation phase. 10 out of 12 SCMs correlated with advanced features of MM. Moreover, 8 out of 12 SCMs had the negative impact on the survival of MM. 5′-Methylthioadenosine may be the only independent prognostic factor in survival period of MM. Conclusion: 10 SCMs identified in our study, which correlated with advanced features of MM, could be potential, novel, non-invasive biomarkers for active disease in MM.Keywords
This publication has 43 references indexed in Scilit:
- Multiple Myeloma Patients Have a Specific Serum Metabolomic Profile That Changes after Achieving Complete RemissionClinical Cancer Research, 2013
- Youden Index and Associated Cut-Points for Three Ordinal Diagnostic GroupsCommunications in Statistics - Simulation and Computation, 2013
- Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active DiseasePLOS ONE, 2013
- Metabolic characterization of a hyper-productive state in an antibody producing NS0 myeloma cell lineMetabolic Engineering, 2009
- Metabolomic Characterization of Human Rectal Adenocarcinoma with Intact Tissue Magnetic Resonance SpectroscopyDiseases of the Colon & Rectum, 2009
- Direct and tumor microenvironment mediated influences of 5′‐deoxy‐5′‐(methylthio)adenosine on tumor progression of malignant melanomaJournal of Cellular Biochemistry, 2008
- Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cellsMolecular and Cellular Biochemistry, 2006
- Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-α–Induced Apoptosis and Cell Growth ArrestClinical Cancer Research, 2005
- MethylthioadenosineThe International Journal of Biochemistry & Cell Biology, 2004
- Surfactant adjunctive therapy forPneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemiaIntensive Care Medicine, 1995